HSDT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HSDT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2025-03-18), Helius Medical Technologies's 14-Day RSI is 34.60.
The industry rank for Helius Medical Technologies's 14-Day RSI or its related term are showing as below:
For the Medical Devices subindustry, Helius Medical Technologies's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Helius Medical Technologies's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Helius Medical Technologies's 14-Day RSI falls into.
The formula for calculating RSI is:
RSI | = | 100 | – | [ 100 | / | ( 1 + Average Gain | / | Average Loss )] |
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Helius Medical Technologies (NAS:HSDT) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Thank you for viewing the detailed overview of Helius Medical Technologies's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.
Dane Andreeff | director, 10 percent owner, officer: President and CEO | C/O ANDREEFF EQUITY ADVISORS L.L.C., 140 E. ST. LUCIA LANE, SANTA ROSA BEACH FL 32459 |
Jeffrey S Mathiesen | director, officer: CFO and Treasurer | 43334 SEVEN MILE RD., SUITE 1000, NORTHVILLE MI 48167 |
Favit-van Pelt Antonella R. | officer: Chief Medical Officer | C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, NEWTOWN PA 18940 |
Paul Buckman | director | 12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402 |
Sherrie L Perkins | director | 5033 TANGLE LANE, HOUSTON TX 77056 |
Jennifer Laux | officer: Chief Commercial Officer | 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN PA 18940 |
Thomas E Griffin | director | C/O ENTELLUS MEDICAL, INC., 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447 |
Blane Walter | director | 500 OLDE WORTHINGTON ROAD, WESTERVILLE OH 43082 |
Edward M Straw | director | C/O ESTEE LAUDER COMPANIES, 767 FIFTH AVENUE, NEW YORK NY 10153 |
Joyce N Laviscount | officer: See Remarks | 100 ENDO BOULEVARD, CHADDS FORD PA 19317 |
Huaizheng Peng | director | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
Philippe Deschamps | director, 10 percent owner, officer: President & CEO | 105 BRADFORD RD, SUITE 420, WEXFORD PA 15090 |
Mitch E Tyler | director | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
Jonathan Sackier | 10 percent owner, officer: Chief Medical Officer | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
A&b (hk) Co Ltd | 10 percent owner | 8/F BLDG A TONGFANG INFORMATION HARBOR, NO 11 LANGSHAN ROAD NANSHAN DISTRICT, SHENZHEN F4 518057 |
From GuruFocus
By Marketwired • 05-29-2024
By Marketwired • 01-22-2025
By Marketwired • 06-17-2024
By Marketwired • 09-30-2024
By GlobeNewswire • 05-07-2024
By Marketwired • 04-24-2024
By Marketwired • 11-18-2024
By GuruFocus Research • 08-13-2024
By Marketwired • 05-06-2024
By GlobeNewswire • 08-16-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.